Keyword Connections

solid tumor

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

31

1 Head-To-Head Comparison of Biological Behavior of Biocompatible Polymers Poly(Ethylene Oxide), Poly(2-Ethyl-2-Oxazoline) and Poly[N-(2-Hydroxypropyl)Methacrylamide] as Coating Materials for Hydroxyapatite Nanoparticles in Animal Solid Tumor Model

2 advancing car t-cell therapy for solid tumors: lessons learned from lymphoma treatment

3 ror1 and ror2 in human malignancies: potentials for targeted therapy

4 the tumor microenvironment and strategies to improve drug distribution

5 kir genes and their ligands predict the response to anti-2 egfr monoclonal antibodies in solid tumors

6 First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

7 Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.

8 A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors.

9 Cancer Stem Cells in Solid Tumors.

10 IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion

11 Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors.

12 A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors.

13 Design and construction of a magnetic targeting pro-coagulant protein for embolic therapy of solid tumors.

14 Sequential Intra-Intercellular Delivery of Nanomedicine for Deep Drug-Resistant Solid Tumor Penetration.

15 profile of nintedanib in the treatment of solid tumors: the evidence to date

16 an overview of viral oncology in italy - report from the pavia meeting on solid tumors

17 the use of linezolid in children with malignant solid tumors

18 high expression of usp22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis

19 strategies to increase drug penetration in solid tumors

20 anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies – a review

21 epigenetic therapy for solid tumors: highlighting the impact of tumor hypoxia

22 radiation- and photo-induced activation of 5-fluorouracil prodrugs as a strategy for the selective treatment of solid tumors

23 not all next generation sequencing diagnostics are created equal: understanding the nuances of solid tumor assay design for somatic mutation detection

24 penetration and silencing activity of vegf dicer substrate sirna vectorized by chitosan nanoparticles in monolayer culture and a solid tumor model in vitro for potential application in tumor therapy

25 chimeric antigen receptor t-cell therapy for solid tumors

26 a phase ib/ii study of ganetespib with doxorubicin in advanced solid tumors including relapsed-refractory small cell lung cancer

27 profile of veliparib and its potential in the treatment of solid tumors

28 Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses

29 MinerVa: A high performance bioinformatic algorithm for the detection of minimal residual disease in solid tumors

30 Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors.

31 Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to access.